Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adjuvant use after resection and platinum-based chemotherapy in stage IB with a T2a tumor at least 4 cm, stage II, or stage IIIA NSCLC.
LAMPGEN ANALYSIS
Why it matters
The indication added postoperative immunotherapy following platinum treatment.
What research teams should watch
Document pathologic staging, tumor size, resection and completed chemotherapy to distinguish this indication from perioperative use.
PRIMARY RECORDS